April 21, 2026
Market insights predict the global pancreatic cancer industry will increase from USD 2.65 billion in 2024 to USD 9.57 billion by 2034, achieving a CAGR of 13.7%. Pancreatic cancer is a deadly disease that starts in the pancreas, an organ that helps d...
February 24, 2026
Based on our market forecasts, the pancreatic cancer precision medicine sector will expand from USD 815.63 million in 2025 to USD 4739.26 million by 2035, experiencing a CAGR of 19.24%....
February 11, 2026
Based on our market forecasts, the metastatic pancreatic cancer treatment market was valued at USD 3.68 billion in 2025 and is projected to grow from USD 3.91 billion in 2026 to approximately USD 6.75 billion by 2035, registering a CAGR of 6.25% duri...
February 24, 2026
According to market projections, the global cancer biopsy market, valued at USD 36.61 billion in 2025, is anticipated to reach USD 205.72 billion by 2035, growing at a CAGR of 18.84% over the next decade. Increasing advancements in biopsy technolog...
January 22, 2026
According to our projections, the global lung cancer trial market, valued at USD 4.34 billion in 2025, is anticipated to reach USD 9.76 billion by 2035, growing at a CAGR of 8.45% over the next decade. The lung cancer trial market is growing due to i...
March 31, 2026
Cancer Biomarkers Market (By Type: Breast cancer, Prostate cancer, Colorectal cancer, Cervical cancer, Liver cancer, Lung cancer, Others; By Biomolecule: Genetic Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Proteomic Biomarkers, Others; B...
April 21, 2026
According to market projections, the global oncology API market, valued at USD 41.79 billion in 2024, is anticipated to reach USD 69.55 billion by 2034, growing at a CAGR of 5.24% over the next decade. The rising prevalence of cancer and the growing ...
April 21, 2026
Market insights predict the global cancer supportive care drugs industry will increase from USD 21.89 billion in 2024 to USD 27.05 billion by 2034, achieving a CAGR of 2.14%. The increased focus on the prevention and management of the adverse effects...
April 21, 2026
According to market projections, the radiation oncology sector is expected to grow from USD 12.45 billion in 2025 to USD 36.78 billion by 2035, reflecting a CAGR of 11.44%. The rising prevalence of cancer and technological advancements drive the glob...
April 21, 2026
Cervical cancer is caused by HPV infections and diagnosed through tests like Pap tests, HPV tests, biopsies, and imaging. Regular screenings and advancements in diagnostic techniques are driving market growth. Initiatives like the WHO’s Global ...
April 21, 2026
Projections indicate that, the global CAR T-cell therapy market will increase from USD 12.88 billion in 2025 to USD 193.6 billion by 2035, experiencing a CAGR of 29.80% over the next 10 years, the CAR T-cell therapy market saw major advancements: MGM...
April 21, 2026
Based on market forecasts, the bladder cancer vaccines market was valued at USD 370.2 million in 2025 and is expected to grow from USD 456.83 million in 2026 to approximately USD 3,031.01 million by 2035, registering a strong CAGR of 23.4% during 202...
April 21, 2026
Based on market forecasts, the global next generation cancer diagnostics market, projected at USD 19.20 billion in 2025, is expected to reach USD 41.64 billion by 2035, growing at a CAGR of 8.05% over the forecast period. The market is driven by the ...
March 12, 2026
Market insights predict the global cancer diagnostics industry will increase from USD 116.42 billion in 2025 to USD 211.85 billion by 2035, achieving a CAGR of 6.17%. The market is growing due to the rising global cancer incidence and increasing awar...
April 24, 2026
Brain Cancer Market (By Product/Solution Type: Therapeutic Treatments, Diagnostic Imaging, Surgical Devices, Supportive Care Products; By Treatment Modality: Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery, Tumor Treating Fi...
April 21, 2026
Projections indicate that, the global liposomal doxorubicin market will increase from USD 1.47 billion in 2025 to USD 2.37 billion by 2035, experiencing a CAGR of 4.96% over the next 10 years. The market is growing due to rising cancer prevalence and...
April 02, 2026
AI In Oncology Market ( By Component: Software Solutions, Hardware, Services; By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer Brain Tumors, Others; By End-User: Hospitals, Pharmaceutical Companies, Research Institutes, ...
February 19, 2026
According to market projections, the global thyroid cancer diagnostics market, valued at USD 3.27 billion in 2025, is anticipated to reach USD 5.49 billion by 2035, growing at a CAGR of 5.34% over the next decade. The thyroid cancer diagnostics marke...
February 03, 2026
Market insights predict, the AI in cancer diagnostics industry is expected to grow from USD 1.17 billion in 2025 to USD 2.86 billion by 2035, driven by a CAGR of 9.35%. AI is revolutionizing cancer diagnostics by enhancing speed, accuracy, and effici...
April 21, 2026
According to market projections, the cancer stem cells sector is expected to grow from USD 3.2 billion in 2024 to USD 8.04 billion by 2034, reflecting a CAGR of 9.64%. Stem cell-based therapies are highly useful in providing high-quality treatment, d...
April 21, 2026
According to market projections, the NUT midline carcinoma treatment sector is expected to grow from USD 23.92 billion in 2025 to USD 68.89 billion by 2035, reflecting a CAGR of 11.15%. The growth of the market is driven by innovations in targeted th...
April 21, 2026
According to market projections, the cancer cachexia sector is expected to grow from USD 2.71 billion in 2025 to USD 4.37 billion by 2035, reflecting a CAGR of 4.9%. It includes detailed analysis of appetite stimulants, cannabinoid receptor agonists,...
April 21, 2026
The advanced liver cancer treatment drugs market is expanding due to increased adoption of systemic therapies over traditional chemotherapy and growing approvals of immuno-oncology agents. North America led the market due to the presence of a well-de...
April 21, 2026
Market insights predict, the oncology automation industry is expected to grow from USD 2.82 billion in 2024 to USD 7.77 billion by 2034, driven by a CAGR of 10.68%. The oncology automation market is growing due to rising cases of cancer, leading to a...
May 04, 2026
Precision Oncology Market (By Product: Therapeutics, Diagnostics; By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Blood Cancer, Prostate Cancer, Others; By End-Use: Pharmaceutical & Biotechnology Companies, Hospita...
April 21, 2026
According to market projections, the global cancer biologics market, valued at USD 110.91 billion in 2024, is anticipated to reach USD 232.02 billion by 2034, growing at a CAGR of 7.66% over the next decade. Rising cancer research is anticipated...
April 21, 2026
According to market projections, the global liver cancer drugs market, valued at USD 3.05 billion in 2024, is anticipated to reach USD 11.5 billion by 2034, growing at a CAGR of 14.2% over the next decade. Liver cancer drugs are medicines used to tre...
January 13, 2026
Market insights predict the global hemato-oncology testing industry will increase from USD 4 billion in 2025 to USD 12.88 billion by 2035, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the to...
April 27, 2026
U.S. Bispecific Antibody Market (By Therapeutic Area/Indication: Oncology, Immuno-inflammation/Autoimmunity, Infectious Diseases, Ophthalmology/Rare Diseases/Others; By Format/Architecture: Dual-variable/IgG-based bispecifics, T-cell Engagers, Bispec...
April 21, 2026
Market insights predict the global cervical cancer treatment industry will increase from USD 8.65 billion in 2024 to USD 14.68 billion by 2034, achieving a CAGR of 5.44%. In 2024, North America led the cervical cancer treatment market, with Europe se...
May 28, 2026
Personalized Cancer Vaccine Market (By Vaccine Type: Neoantigen-Based Vaccines, Dendritic Cell Vaccines, Tumor Cell Vaccines, Viral Vector-Based Vaccines; By Cancer Type: Melanoma, Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Other...
April 21, 2026
According to market projections, the gene therapies for cancer treatment sector is expected to grow from USD 8.28 billion in 2024 to USD 238.77 billion by 2034, reflecting a CAGR of 39.94%. The rising prevalence of cancer and the growing demand for p...
January 20, 2026
Projections indicate the global chemotherapy market will increase from USD 10.29 billion in 2025 to USD 21.33 billion by 2035, experiencing a CAGR of 7.56% over the next 10 years. In 2024, North America led the global chemotherapy market with a 45% s...
April 21, 2026
The market is growing due to its ability to accelerate drug discovery and optimize personalized treatment strategies. This leads to faster development timelines, reduced costs, and improved patient outcomes....
April 24, 2026
CAR T-Cell Neurotoxicity Detection Market (By Detection Method: Biomarker-based Detection, AI-based & Wearable Monitoring Neuroimaging, Electrophysiology, Cognitive & Behavioral Assessment Tools; By Product/Service Type: Diagnostic Kits &...
April 21, 2026
According to forecasts, the Japan cell cancer vaccine market will grow from USD 320.6 million in 2024 to USD 576.4 million by 2034, with an expected CAGR of 6.04%. The Japan cell cancer vaccine market is expanding due to rising incidences of cancer a...
April 21, 2026
According to market projections, the cancer vaccines sector is expected to grow from USD 11.38 billion in 2024 to USD 33.61 billion by 2034, reflecting a CAGR of 11.44%. The increasing prevalence of cancer, research and development and continuous eff...
May 28, 2026
Metastatic Breast Cancer Market (By Therapy Type: Chemotherapy, Hormonal Therapy, Targeted Therapy, Immunotherapy; By Cancer Subtype: Hormone Receptor Positive (HR+) / HER2 Negative, HER2 Positive, Triple-Negative Breast Cancer (TNBC); By Route of Ad...
March 12, 2026
Projections indicate that, the global single cell analysis market will increase from USD 6.16 billion in 2025 to USD 34.33 billion by 2035, experiencing a CAGR of 18.74% over the next 10 years. Across the world, growing cancer incidents and chronic d...
April 08, 2026
Oncology Molecular Diagnostics Market ( By Type: Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer Others; By Product: Instruments, Reagents, Others; By Technology: PCR, In-situ...
May 28, 2026
Colorectal Cancer Diagnostics Market (By Test Type: Stool-based Tests, Blood-Based Tests, Imaging Tests, Endoscopic Tests, Biopasy; By Technology: Molecular Diagnostics, Immunoassays, Clinical Chemistry, Imaging Technology; By Application: Screening,...
April 21, 2026
Market insights predict, the non-small cell lung cancer therapeutics industry is expected to grow from USD 21.5 billion in 2024 to USD 71.2 billion by 2034, driven by a CAGR of 12.74%. The non-small cell lung cancer therapeutics market is expanding d...
April 21, 2026
According to market projections, the global head & neck cancer therapeutics market, valued at USD 2.65 billion in 2025, is anticipated to reach USD 8.14 billion by 2035, growing at a CAGR of 11.87% over the next decade. A surge in tobacco and alc...
April 21, 2026
Based on market forecasts, the global oncology market, projected at USD 225.05 billion in 2024, is expected to reach USD 748.17 billion by 2035, growing at a CAGR of 11.54% over the forecast period.The oncology market is expanding due to rising can...
April 21, 2026
Projections indicate that, U.S. cell therapy industry is projected to rise from USD 6.62 billion in 2024 to USD 46.26 billion by 2034, reflecting a CAGR of 21.46% over the next decade. The increasing prevalence of chronic conditions is driving the gr...
April 21, 2026
Based on market forecasts, the global cell counting market, projected at USD 10.24 billion in 2024, is expected to reach USD 22.85 billion by 2034, growing at a CAGR of 8.41% over the forecast period. The cell counting market is growing because incor...
January 16, 2026
According to market projections, the global hyperthermia cancer treatment market, valued at USD 210.54 million in 2025, is anticipated to reach USD 380.63 million by 2035, growing at a CAGR of 6.1% over the next decade. The rising incidences of cance...
March 25, 2026
U.S. CAR T-Cell Therapies Market (By Drug Type: Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene Autoleucel, Others; By Indication: Lymphoma, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Others; By E...
May 25, 2026
Immunohistochemistry Market (By Product: Antibodies, Reagents, Equipment, Kits; By Application: Diagnostics, Drug Development & Research, Forensic Applications, Academic Research; By Technique: Immunofluorescence IHC, Chromogenic IHC, Multiplex I...
June 03, 2026
U.S. Non-Invasive Cancer Diagnostics Market (By Product Type: Instruments, Reagents & Kits, Software & Services; By Therapeutic Area: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Liquid Biopsy, Imaging Technology, Microa...
April 21, 2026
Based on market forecasts, the global whole genome sequencing market, projected at USD 2.15 billion in 2024, is expected to reach USD 15.96 billion by 2034, growing at a CAGR of 22.2% over the forecast period. The market is growing due to increasing ...
April 21, 2026
Based on market forecasts, the global advanced liver cancer market, projected at USD 2.65 billion in 2024, is expected to reach USD 8.2 billion by 2034, growing at a CAGR of 11.94% over the forecast period. Emergence of diverse severe liver issues ...
April 21, 2026
Based on market forecasts, the circulating tumor cells sector will expand from USD 13.06 billion in 2024 to USD 46.9 billion by 2034, experiencing a CAGR of 13.64%. The growing prevalence of cancer drives the market’s growth....
April 21, 2026
Expansion of healthcare facilities, especially in emerging economies, is improving access to advanced cancer treatments, further supporting market expansion. North America has a robust healthcare system with significant spending on advanced treatme...
April 21, 2026
Based on market forecasts, the breast cancer liquid biopsy sector will expand from USD 229.6 million in 2025 to USD 912.83 million by 2035, experiencing a CAGR of 14.8%. Breast cancer cases are rising day by day, which is increasing the demand for bi...
April 30, 2026
Autologous CAR-T Cell Therapy Market (By Product Type: CD19-Directed CAR-T Cell Therapy, BCMA-Directed CAR-T Cell Therapy, Other Antigen-Directed CAR-T Cell Therapy; By Application: Acute Lymphoblastic Leukemia, Non-Hodgkin Lymphoma, Multiple Myeloma...
April 21, 2026
Market insights predict, the breast cancer screening tests industry is expected to grow from USD 4.44 billion in 2024 to USD 8.77 billion by 2034, driven by a CAGR of 7.04%. The breast cancer screening tests market is growing due to its major applica...
April 21, 2026
Market insights predict, the breast implants industry is expected to grow from USD 2.72 billion in 2024 to USD 5.62 billion by 2034, driven by a CAGR of 7.54%. Breast reconstruction is gaining traction for its psychosexual benefits post-cancer surger...
April 21, 2026
According to market projections, the CDK4/6 inhibitors sector is expected to grow from USD 11.38 billion in 2024 to USD 46.96 billion by 2034, reflecting a CAGR of 15.34%. The rising prevalence of cancer and growing research and development activit...
April 21, 2026
According to market projections, the DNA vaccine sector is expected to grow from USD 553.89 million in 2024 to USD 1041.68 million by 2034, reflecting a CAGR of 6.52%. In 2024, North America led the global DNA vaccine market, with Asia-Pacific expect...
April 21, 2026
According to market projections the hospital services market size is calculated at $12.08 tn in 2025 is to hit $26.56 tn by 2034, seeing trends like digital health adoption, telemedicine growth, personalized care, and integration of AI for diagnosis ...
April 21, 2026
Projections indicate that, the global cellular immunotherapy market will increase from USD 11.33 billion in 2024 to USD 85.78 billion by 2034, experiencing a CAGR of 22.45% over the next 10 years. The increasing investments in R&D activiti...
April 21, 2026
According to market projections, the blood product sector is expected to grow from USD 39.96 billion in 2025 to USD 62.65 billion by 2035, reflecting a CAGR of 4.6%, driven by rising demand in surgeries, cancer care, and trauma cases. North America l...
April 21, 2026
The market is growing due to the strong clinical success of BCMS-targeted therapies and rising cases of relapsed or refractory patients. Improved regulatory support and expanded treatment access are further accelerating market adoption. ...
April 21, 2026
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and c...
April 21, 2026
According to market projections, the global anticancer drugs market, valued at USD 167.09 billion in 2024, is anticipated to reach USD 401.32 billion by 2034, growing at a CAGR of 9.14% over the next decade. The growing aging population is more susce...
April 21, 2026
Market insights predict, the compounding chemotherapy industry is expected to grow from USD 5.34 billion in 2024 to USD 9.97 billion by 2034, driven by a CAGR of 6.44%.The compounding chemotherapy market is growing due to rising cases of cancer and g...
+1 9197 992 333
+91 93077 85324
